DHEA for Women: Evidence, Uses & Interactions
Researched by DoseRoutine Research TeamReviewed for accuracy by Nicholas Alexander, RSE, SO, PMPLast updated Educational reference only — not medical advice. Always confirm dosing and safety decisions with a licensed clinician.
Summary
Dehydroepiandrosterone (DHEA) is an adrenal steroid hormone that serves as a precursor to both estrogen and testosterone. It is sold as a supplement in the US but is a prescription-only hormone in the UK, Canada, and most of Europe. Trials in women support use for adrenal insufficiency (physiologic replacement), possibly for post-menopausal vaginal atrophy (as intravaginal prasterone), and for a subset of women undergoing IVF with poor ovarian reserve. Evidence level: moderate for adrenal insufficiency and vaginal prasterone, limited for systemic anti-aging use, insufficient for libido in premenopausal women.
Key facts
| Studied dose range | 10–50 mg/day oral for postmenopausal use; 6.5 mg intravaginal (prasterone) for vaginal atrophy. Physician-supervised only. |
|---|---|
| Common forms | Oral capsules (US OTC), intravaginal inserts (prasterone, prescription), sublingual |
| Evidence level | Moderate |
| Main interaction risks | Androgenic side effects, interaction with HRT and hormone-sensitive cancers, prescription-only in many countries |
What the research shows
Panjari & Davis (Climacteric 2011) systematically reviewed oral DHEA for menopausal symptoms and concluded there was no consistent benefit for hot flashes, mood, or well-being at doses ≤50 mg/day, though small subgroups reported subjective sexual-function improvements.
Intravaginal prasterone (Intrarosa, 6.5 mg) was approved by the FDA in 2016 for postmenopausal dyspareunia. RCTs (Menopause 2016) showed statistically significant improvements in vaginal cell maturation and pain during intercourse versus placebo.
For adrenal insufficiency (Addison's disease and hypopituitarism), DHEA replacement at 25–50 mg/day improves subjective well-being and sexual function in women (Journal of Clinical Endocrinology & Metabolism 2000; Endocrine Reviews 2005). This is a physician-supervised replacement therapy, not general supplementation.
IVF context: some evidence (Reproductive BioMedicine Online 2015) suggests DHEA 75 mg/day for 12+ weeks before stimulation may improve outcomes in women with diminished ovarian reserve, though results are inconsistent.
Androgenic side effects (acne, hair thinning at the crown, facial hair, voice changes) become relevant at doses above 25 mg/day and are the main reason to avoid casual OTC use.
Turn this evidence into a personal safety check for DHEA.
The interaction checker cross-references DHEA against HRT, birth control, thyroid medication, SSRIs, and every other item in your stack — using the same clinical sources cited above.
Check DHEA on the interaction checkerInteractions
Interaction risk is what makes women's-health supplements uniquely tricky — HRT, birth control, thyroid medication and SSRIs all share metabolic pathways with common botanicals. Each item below lists the mechanism and what to actually watch for.
- HRT (estradiol, progesterone)Mechanism: DHEA converts peripherally to both estrogen and testosterone; additive hormonal effect.Watch for: Not typically combined without endocrinology oversight.Check DHEA + HRT (estradiol, progesterone) on the interaction checker
- Aromatase inhibitors (anastrozole, letrozole)Mechanism: DHEA is a substrate for peripheral aromatization to estrone.Watch for: Avoid in women on AIs for breast cancer.Check DHEA + Aromatase inhibitors (anastrozole, letrozole) on the interaction checker
- TamoxifenMechanism: Peripheral estrogen production from DHEA may partly offset SERM effect.Watch for: Avoid without oncology sign-off.Check DHEA + Tamoxifen on the interaction checker
- Testosterone therapyMechanism: Additive androgenic effect.Watch for: Avoid or use only with careful lab monitoring.Check DHEA + Testosterone therapy on the interaction checker
- Insulin and diabetes medicationsMechanism: DHEA can modestly affect insulin sensitivity in either direction.Watch for: Monitor glucose if diabetic.Check DHEA + Insulin and diabetes medications on the interaction checker
- Anticonvulsants and CYP inducers (carbamazepine, phenytoin)Mechanism: Altered DHEA metabolism.Watch for: Discuss with prescriber.Check DHEA + Anticonvulsants and CYP inducers (carbamazepine, phenytoin) on the interaction checker
Who should be cautious
- History of breast, uterine, ovarian, or hormone-sensitive cancer.
- Polycystic ovary syndrome (PCOS) — often already have elevated DHEA-S; supplementation worsens it.
- Uncontrolled acne, hirsutism, or male-pattern hair loss.
- Pregnancy and breastfeeding — avoid.
- Not for premenopausal women without a specific endocrine indication and physician oversight.
FAQ
Can I take DHEA with HRT?
Only under endocrinology supervision. DHEA converts peripherally to both estrogen and testosterone, so adding it to prescribed HRT stacks hormone exposure in ways that are hard to titrate without labs. If your HRT isn't working, the answer is an HRT-adjustment conversation, not adding DHEA.
Can I take DHEA with birth control?
This is not a routine combination and requires clinician oversight. Combined oral contraceptives suppress endogenous adrenal androgens; adding DHEA can produce unpredictable androgenic effects. Do not self-combine.
How long does DHEA take to work?
For vaginal prasterone, cellular effects show up in 12 weeks. For oral DHEA in adrenal insufficiency, subjective well-being changes take 8–16 weeks. For IVF ovarian-reserve protocols, DHEA is typically loaded for 12 weeks before stimulation.
DHEA vs low-dose testosterone for libido?
For postmenopausal HSDD, low-dose transdermal testosterone (physician-prescribed) has stronger, more targeted evidence than DHEA. DHEA produces both estrogenic and androgenic effects peripherally, which is harder to control. Prescription decisions belong with your clinician.
Is DHEA safe long-term?
The long-term safety of general OTC use is not well characterised. Short-to-medium term use at 10–25 mg/day in postmenopausal women is generally tolerated. Higher doses and longer durations raise androgenic and theoretical cancer-risk concerns.
Why is DHEA prescription-only in some countries?
The UK, Canada, most of the EU, and Australia classify DHEA as a prescription hormone because of its systemic hormonal effects, contamination concerns with OTC preparations, and misuse potential. In the US it's sold as a dietary supplement.
Where can I check DHEA interactions?
Add DHEA to the DoseRoutine interaction checker at doseroutine.com/interaction-checker alongside your HRT, birth control, tamoxifen, or aromatase inhibitor to see pairwise flags.
Taking DHEA alongside HRT, birth control, or other supplements?
Get access to all DoseRoutine tools — check your full routine for interactions, log doses and get reminders.
Sign up freeSources
- Panjari M, Davis SR. Climacteric 2011 — DHEA for postmenopausal women.
- Labrie F et al. Menopause 2016 — Intravaginal prasterone (DHEA) trial for postmenopausal dyspareunia.
- Arlt W et al. J Clin Endocrinol Metab 2000 — DHEA replacement in adrenal insufficiency.
- Endocrine Society Clinical Practice Guideline — Androgen therapy in women (2014).
- NIH ODS — DHEA fact sheet.
Source: DoseRoutine Library — doseroutine.com/library/womens-health/dhea-women